Lipopolysaccharide-Induced CD300b Receptor Binding to Toll-like Receptor 4 Alters Signaling to Drive Cytokine Responses that Enhance Septic Shock

Immunity

Volumn 44, Issue 6, 2016, Pages 1365-1378

  Voss, Oliver H ^a   Murakami, Yousuke ^a   Pena, Mirna Y ^a   Lee, Ha Na ^a   Tian, Linjie ^a   Margulies, David H ^a   Street, Jonathan M ^b   Yuen, Peter S T ^b   Qi, Chen Feng ^a   Krzewski, Konrad ^a   Coligan, John E ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; BACTERIUM LIPOPOLYSACCHARIDE; CD300B ANTIGEN; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 6; KILLER CELL ACTIVATING RECEPTOR ASSOCIATED PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE P38; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOID DIFFERENTIATION FACTOR 88; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE 3 KINASE; PROTEIN KINASE B; PROTEIN KINASE SYK; STRESS ACTIVATED PROTEIN KINASE; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; IMMUNOGLOBULIN RECEPTOR; LIPOPOLYSACCHARIDE; LMIR5 PROTEIN, MOUSE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BINDING; TICAM-1 PROTEIN, MOUSE; TLR4 PROTEIN, MOUSE; VESICULAR TRANSPORT ADAPTOR PROTEIN;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; BACTERIAL PERITONITIS; BONE MARROW CELL; COMPLEX FORMATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDOTOXEMIA; ENZYME ACTIVATION; HEK293 CELL LINE; IMMUNE RESPONSE; IMMUNOREGULATION; IN VIVO STUDY; INFLAMMATION; INTRACELLULAR SIGNALING; L929 CELL LINE; MACROPHAGE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RECEPTOR BINDING; SEPTIC SHOCK; ANIMAL; C57BL MOUSE; GENETICS; HUMAN; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; PERITONITIS; SEPSIS; SIGNAL TRANSDUCTION;

ADAPTOR PROTEINS, VESICULAR TRANSPORT; ANIMALS; HEK293 CELLS; HUMANS; INTERLEUKIN-10; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELOID DIFFERENTIATION FACTOR 88; NF-KAPPA B; PERITONITIS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTEIN BINDING; RECEPTORS, IMMUNOLOGIC; SEPSIS; SIGNAL TRANSDUCTION; SYK KINASE; TOLL-LIKE RECEPTOR 4;

EID: 84973532257     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2016.05.005     Document Type: Article

References (41)

1. Akashi S., Saitoh S., Wakabayashi Y., Kikuchi T., Takamura N., Nagai Y., Kusumoto Y., Fukase K., Kusumoto S., Adachi Y., et al. Lipopolysaccharide interaction with cell surface Toll-like receptor 4-MD-2: higher affinity than that with MD-2 or CD14. J. Exp. Med. 2003, 198:1035-1042.
2. Banerjee A., Gugasyan R., McMahon M., Gerondakis S. Diverse Toll-like receptors utilize Tpl2 to activate extracellular signal-regulated kinase (ERK) in hemopoietic cells. Proc. Natl. Acad. Sci. USA 2006, 103:3274-3279.
3. Borrego F. The CD300 molecules: an emerging family of regulators of the immune system. Blood 2013, 121:1951-1960.
4. Bouchon A., Facchetti F., Weigand M.A., Colonna M. TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature 2001, 410:1103-1107.
5. Chanteux H., Guisset A.C., Pilette C., Sibille Y. LPS induces IL-10 production by human alveolar macrophages via MAPKinases- and Sp1-dependent mechanisms. Respir. Res. 2007, 8:71.
6. Clatworthy M.R., Smith K.G. FcgammaRIIb balances efficient pathogen clearance and the cytokine-mediated consequences of sepsis. J. Exp. Med. 2004, 199:717-723.
7. Cohen J. The immunopathogenesis of sepsis. Nature 2002, 420:885-891.
8. da Silva Correia J., Soldau K., Christen U., Tobias P.S., Ulevitch R.J. Lipopolysaccharide is in close proximity to each of the proteins in its membrane receptor complex. transfer from CD14 to TLR4 and MD-2. J. Biol. Chem. 2001, 276:21129-21135.
9. Gangloff S.C., Zähringer U., Blondin C., Guenounou M., Silver J., Goyert S.M. Influence of CD14 on ligand interactions between lipopolysaccharide and its receptor complex. J. Immunol. 2005, 175:3940-3945.
10. Hamerman J.A., Tchao N.K., Lowell C.A., Lanier L.L. Enhanced Toll-like receptor responses in the absence of signaling adaptor DAP12. Nat. Immunol. 2005, 6:579-586.
11. Henson P.M., Bratton D.L. Antiinflammatory effects of apoptotic cells. J. Clin. Invest. 2013, 123:2773-2774.
12. Hotchkiss R.S., Monneret G., Payen D. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat. Rev. Immunol. 2013, 13:862-874.
13. Howard M., Muchamuel T., Andrade S., Menon S. Interleukin 10 protects mice from lethal endotoxemia. J. Exp. Med. 1993, 177:1205-1208.
14. Huang X., Venet F., Wang Y.L., Lepape A., Yuan Z., Chen Y., Swan R., Kherouf H., Monneret G., Chung C.S., Ayala A. PD-1 expression by macrophages plays a pathologic role in altering microbial clearance and the innate inflammatory response to sepsis. Proc. Natl. Acad. Sci. USA 2009, 106:6303-6308.
15. Iwasaki A., Medzhitov R. Control of adaptive immunity by the innate immune system. Nat. Immunol. 2015, 16:343-353.
16. Izawa K., Kitaura J., Yamanishi Y., Matsuoka T., Oki T., Shibata F., Kumagai H., Nakajima H., Maeda-Yamamoto M., Hauchins J.P., et al. Functional analysis of activating receptor LMIR4 as a counterpart of inhibitory receptor LMIR3. J. Biol. Chem. 2007, 282:17997-18008.
17. Kagan J.C., Medzhitov R. Phosphoinositide-mediated adaptor recruitment controls Toll-like receptor signaling. Cell 2006, 125:943-955.
18. Kim S.H., Kim J., Sharma R.P. Inhibition of p38 and ERK MAP kinases blocks endotoxin-induced nitric oxide production and differentially modulates cytokine expression. Pharmacol. Res. 2004, 49:433-439.
19. Ling G.S., Bennett J., Woollard K.J., Szajna M., Fossati-Jimack L., Taylor P.R., Scott D., Franzoso G., Cook H.T., Botto M. Integrin CD11b positively regulates TLR4-induced signalling pathways in dendritic cells but not in macrophages. Nat. Commun. 2014, 5:3039.
20. Martínez-Barriocanal A., Comas-Casellas E., Schwartz S., Martín M., Sayós J. CD300 heterocomplexes, a new and family-restricted mechanism for myeloid cell signaling regulation. J. Biol. Chem. 2010, 285:41781-41794.
21. Moshkovits I., Karo-Atar D., Itan M., Reichman H., Rozenberg P., Morgenstern-Ben-Baruch N., Shik D., Ejarque-Ortiz A., Hershko A.Y., Tian L., et al. CD300f associates with IL-4 receptor α and amplifies IL-4-induced immune cell responses. Proc. Natl. Acad. Sci. USA 2015, 112:8708-8713.
22. Murakami Y., Tian L., Voss O.H., Margulies D.H., Krzewski K., Coligan J.E. CD300b regulates the phagocytosis of apoptotic cells via phosphatidylserine recognition. Cell Death Differ. 2014, 21:1746-1757.
23. Muroi M., Ohnishi T., Tanamoto K. Regions of the mouse CD14 molecule required for toll-like receptor 2- and 4-mediated activation of NF-κ B. J. Biol. Chem. 2002, 277:42372-42379.
24. Nagaoka K., Takahara K., Tanaka K., Yoshida H., Steinman R.M., Saitoh S., Akashi-Takamura S., Miyake K., Kang Y.S., Park C.G., Inaba K. Association of SIGNR1 with TLR4-MD-2 enhances signal transduction by recognition of LPS in gram-negative bacteria. Int. Immunol. 2005, 17:827-836.
25. Nakahashi-Oda C., Tahara-Hanaoka S., Shoji M., Okoshi Y., Nakano-Yokomizo T., Ohkohchi N., Yasui T., Kikutani H., Honda S., Shibuya K., et al. Apoptotic cells suppress mast cell inflammatory responses via the CD300a immunoreceptor. J. Exp. Med. 2012, 209:1493-1503.
26. Saraiva M., O'Garra A. The regulation of IL-10 production by immune cells. Nat. Rev. Immunol. 2010, 10:170-181.
27. Shimazu R., Akashi S., Ogata H., Nagai Y., Fukudome K., Miyake K., Kimoto M. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J. Exp. Med. 1999, 189:1777-1782.
28. Shin H.J., Lee H., Park J.D., Hyun H.C., Sohn H.O., Lee D.W., Kim Y.S. Kinetics of binding of LPS to recombinant CD14, TLR4, and MD-2 proteins. Mol. Cells 2007, 24:119-124.
29. Siewe L., Bollati-Fogolin M., Wickenhauser C., Krieg T., Müller W., Roers A. Interleukin-10 derived from macrophages and/or neutrophils regulates the inflammatory response to LPS but not the response to CpG DNA. Eur. J. Immunol. 2006, 36:3248-3255.
30. Thomas C.J., Kapoor M., Sharma S., Bausinger H., Zyilan U., Lipsker D., Hanau D., Surolia A. Evidence of a trimolecular complex involving LPS, LPS binding protein and soluble CD14 as an effector of LPS response. FEBS Lett. 2002, 531:184-188.
31. Tian L., Choi S.C., Murakami Y., Allen J., Morse H.C., Qi C.F., Krzewski K., Coligan J.E. p85α recruitment by the CD300f phosphatidylserine receptor mediates apoptotic cell clearance required for autoimmunity suppression. Nat. Commun. 2014, 5:3146.
32. Totsuka N., Kim Y.G., Kanemaru K., Niizuma K., Umemoto E., Nagai K., Tahara-Hanaoka S., Nakahasi-Oda C., Honda S., Miyasaka M., et al. Toll-like receptor 4 and MAIR-II/CLM-4/LMIR2 immunoreceptor regulate VLA-4-mediated inflammatory monocyte migration. Nat. Commun. 2014, 5:4710.
33. Turnbull I.R., Colonna M. Activating and inhibitory functions of DAP12. Nat. Rev. Immunol. 2007, 7:155-161.
34. Turnbull I.R., McDunn J.E., Takai T., Townsend R.R., Cobb J.P., Colonna M. DAP12 (KARAP) amplifies inflammation and increases mortality from endotoxemia and septic peritonitis. J. Exp. Med. 2005, 202:363-369.
35. Turnbull I.R., Gilfillan S., Cella M., Aoshi T., Miller M., Piccio L., Hernandez M., Colonna M. Cutting edge: TREM-2 attenuates macrophage activation. J. Immunol. 2006, 177:3520-3524.
36. van der Poll T., Marchant A., Buurman W.A., Berman L., Keogh C.V., Lazarus D.D., Nguyen L., Goldman M., Moldawer L.L., Lowry S.F. Endogenous IL-10 protects mice from death during septic peritonitis. J. Immunol. 1995, 155:5397-5401.
37. Wenzel R.P., Edmond M.B. Septic shock--evaluating another failed treatment. N. Engl. J. Med. 2012, 366:2122-2124.
38. Wright S.D., Ramos R.A., Tobias P.S., Ulevitch R.J., Mathison J.C. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990, 249:1431-1433.
39. Yamanishi Y., Kitaura J., Izawa K., Matsuoka T., Oki T., Lu Y., Shibata F., Yamazaki S., Kumagai H., Nakajima H., et al. Analysis of mouse LMIR5/CLM-7 as an activating receptor: differential regulation of LMIR5/CLM-7 in mouse versus human cells. Blood 2008, 111:688-698.
40. Yamanishi Y., Takahashi M., Izawa K., Isobe M., Ito S., Tsuchiya A., Maehara A., Kaitani A., Uchida T., Togami K., et al. A soluble form of LMIR5/CD300b amplifies lipopolysaccharide-induced lethal inflammation in sepsis. J. Immunol. 2012, 189:1773-1779.
41. Zanoni I., Ostuni R., Marek L.R., Barresi S., Barbalat R., Barton G.M., Granucci F., Kagan J.C. CD14 controls the LPS-induced endocytosis of Toll-like receptor 4. Cell 2011, 147:868-880.